Nordea Investment Management AB Lowers Stake in Cigna Group $CI

Nordea Investment Management AB trimmed its position in Cigna Group (NYSE:CI) by 12.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,277,393 shares of the health services provider’s stock after selling 180,829 shares during the quarter. Nordea Investment Management AB owned 0.48% of Cigna Group worth $353,800,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Harbor Capital Advisors Inc. raised its holdings in Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after buying an additional 49 shares during the period. Collier Financial acquired a new stake in Cigna Group during the 3rd quarter valued at approximately $34,000. Founders Capital Management increased its stake in shares of Cigna Group by 53.0% in the third quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock worth $44,000 after buying an additional 53 shares during the last quarter. Twin Peaks Wealth Advisors LLC bought a new stake in shares of Cigna Group in the 2nd quarter worth about $52,000. Finally, Measured Wealth Private Client Group LLC bought a new stake in Cigna Group in the third quarter valued at about $56,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This represents a 23.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.

Cigna Group Stock Down 0.7%

CI stock opened at $262.83 on Friday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The firm has a market cap of $69.26 billion, a PE ratio of 11.85, a PEG ratio of 0.91 and a beta of 0.27. The company has a fifty day simple moving average of $277.86 and a 200 day simple moving average of $281.57. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same period in the previous year, the company earned $6.64 EPS. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were issued a $1.56 dividend. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend was Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.4%. Cigna Group’s payout ratio is currently 28.13%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. UBS Group restated a “buy” rating and set a $375.00 price objective on shares of Cigna Group in a research note on Monday, February 9th. Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Royal Bank Of Canada dropped their price objective on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a report on Friday, February 6th. Piper Sandler cut their price objective on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Finally, Barclays reduced their price target on Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research report on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $333.11.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.